News

UroToday12h
Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting
Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) Efficacy and safety ...
UroToday19h
EAU 2025: Discussant: NIAGARA - Surgical Outcomes and Neoadjuvant Safety with Perioperative Durvalumab for Muscle-Invasive Bladder Cancer
(UroToday.com) The 2025 EAU annual meeting featured a game changer session and a discussant presentation by Dr. Geraldine Pignot. Dr. Pignot discussed Dr. Catto’s presentation “NIAGARA - Surgical ...